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The  central  role  of immune  lymphoid cells  in  the  manifestation  of diverse  im- 
munological  reactions  in  delayed  hypersensitivity,  transplantation,  and  autoim- 
munity is  well  established,  but  the  mechanism  by which  the  sensitized  cells  exert 
their effect is still largely unknown. The introduction of tissue culture methods rep- 
resents  a  major advance in  this  area,  and  cell-mediated  immunity against histoin- 
compatible  target  cells  can  now  be  demonstrated  by  the  capacity  of  specifically 
sensitized lymphoid cells to kill normal or neoplastic target cells in vitro (1-8). 
Cytotoxicity by sensitized  cells  fulfils  requirements  for immunological specificity 
(9),  is preceded as a rule by aggregation of the lymphoid cells around the target cells, 
and is abolished if the two cell  types are separated by impermeable diffusion mem- 
branes (8). 
However, not only specifically sensitized cells  but normal allogeneic  (though not 
syngeneic) cells were also found to kill H-2 incompatible target cells of mouse origin 
in vitro (10-12) if heterologous antibodies or phytohemagglutinin was present in the 
medium. Although this reaction may represent  the induction of a  primary immune 
response  in  vitro,  this  seemed  less  probable  since lymphoid cells,  which would  be 
genetically unable to react immunologically against the targets, were still capable of 
mediating target cell  death  (11).  The only variable  that determined cytotoxicity in 
this  case  seemed  to  be  the  presence  of foreign histocompatibility  antigens  on  the 
lymphoid cells.  Presumably,  target cells were damaged by dose confrontation with 
cells  carrying incompatible surface isoantigenic determinants.  An analogous concept 
was also put forward by HellstrSm et al.  (13)  as an explanation of the phenomenon 
of reduced  tumor growth in  semisyngeneic F1  hybrid mice as  compared  to  tumor 
growth in syngeneic hosts (14).  The reaction was termed "allogeneic inhibition". 
In the present  study,  attempts  have been made to test  the validity of the 
above  hypothesis  concerning  contact-induced  cytotoxicity  by  incompatible 
lymphoid cells. Interest has been directed to the demonstration of cytotoxocity 
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with  lymphoid  cells  genetically  unable  to  react  immunologicaUy  against 
target  cells  and  with  X-irradiated  lymphoid  cells.  Furthermore,  the  con- 
cept  that  target  cell  death  is  caused  by  confrontation  with  foreign  histo- 
compatibility  antigens  has  been  investigated  by  experiments  aimed  at  the 
suppression  of  cytotoxicity  by  blocking  the  antigens  on  the  lymphoid  cells 
with specific isoantibodies.  Part of this work has been published in preliminary 
form (11,  12,  15). 
Materials  and  Methods 
M/ce.--The following inbred strains of mice were used in the present study: A/Sn (H-2~); 
C57BL/KL and C57L/K1, both (H-2b); DBA/K1 (H-ga); A.CA/K1 (H-2~);  C3H/K1  (I-I-2  k) 
and A.SW/K1 (H-Z'); and F1 hybrids produced by crossing two of the strains. 
Tumors.--Tumors  MC57G,  MC57S,  and  MC57T  are  methylcholanthrene-induced  sar- 
comas which originated in the C57BL strain. They were serially passaged by the subcutaneous 
inoculation of trypsinized cells in the C57BL strain. Tumor MCAG is a methylcholanthrene- 
induced tumor which originated in an (A X  A.CA)F1 hybrid mouse. A parental strain variant, 
specific for strain A/Sn, was isolated from this tumor. Transplantation and serological studies 
have revealed that this tumor, designated MCAGA, behaves phenotypically as an A  strain 
tumor  (16).  Tumor  MACD  is  a  methylcholanthrene-induced  sarcoma  indigenous  to  the 
(A X  A.CA)F1 hybrid. Sarcoma MDHC was induced by methylcholanthrene in a  (C3H X 
DBA)F1 hybrid. None of the above tumors grew nonspecifically in H-2 incompatible recipients. 
Antiserum.--Antiserum was prepared  by weekly intraperitoneal injections of spleen and 
lymph node cell suspensions.  Mter 6-10 injections, blood was collected from the retroorbital 
sinus and allowed to clot at room temperature. The sere were pooled and stored at  --20°C 
before use. The various antisera against different H-2 isoantigens used in the present study 
were tested for their content of hemagglutinating (HA) antibodies by the technique of Gorer 
and Mikulska (17) as modified by Stimpfling (18). For tissue culture experiments, all sera were 
diluted so that the final HA fiter in the medium would average 1/10--1/20. 
Lymph Node and Spleen Cd/s.--These were obtained from noulmmune  adult  mice. Cell 
suspensions  were obtained by pressing the organs through staluless steel screens into Eagle's 
in Earle's medium. The cells were washed twice and counted in a Biirker hemocytometer. 
Tissue  Culture Techn/que.--Viable cell  suspensions  from  various  target  sarcomas  were 
obtained by trypsinizing solid tumors [0.25%  trypsin  in  balanced  salt  solution (BSS)]  cut 
into small pieces with a pair of scissors.  Trypsinizafion was carried out for 45 rain at 37°C. 
Thereafter the cells were washed twice, and the number of viable tumor cells estimated by the 
trypan blue dye exclusion test in a  Bfirker chamber. The tumor cells were diluted, and l0  s 
viable cells were cultivated in 13 X  100 mm tubes kept at an angle of 15  ° in the presence of 
2 ml of Eagle's in Earle's medium containing 15% fetal calf serum (Microbiological Associates, 
Bethesda,  Md.).  Mycostatin  (30  l'U/ml), penicillin  (500  IU/ml),  and  streptomycin  (0.1 
g/ml) were present in the medium. Mter 24-48 hr incubation at 37°C,  the tumor cells were 
used for the experiment. Medium was changed and  10 g/ml of phytohemagglutiuln (PHA) 
(Wellcome Research Laboratories,  Beckenham,  England)  was added.  30 mill later,  0.1  ml 
lymphoid cell suspension containing 10  T  viable lymphoid cells was added to the tubes. In some 
experiments where serum was used, the lymphoid cells were first mixed with antiserum  at 
37°C for 30 rain prior to addition to the target cells. Mter 48 hr, the tubes were centrifuged and 
the superuatant discarded, 2 ml of 0.25% trypsin was added for 30 rain at 37°C, and the cells 
were washed once. Most of the superuatant  was carefully withdrawn and the cells were re- 
suspended in a small volume of medium. The total number of tumor cells per tube was calcu- 
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RESULTS 
Cytotoxic  Effect  of  Allogeneic and  Semisyngeneic  Nonimmune  Lymphoid 
Cells.--Nonimmune  allogeneic lymphoid cells are capable of causing cytotoxie 
damage to  H-2  incompatible normal and neoplastic  cells in  the  presence  of 
PHA.  Since syngeneic cells were not active in the presence of PHA,  an al- 
ternative explanation of the  reaction would  be  that  a  primary immune re- 
sponse was initiated in the lymphoid ceils leading to the death of the target 
cells.  In order to study this possibility, lymphoid cells  from Fs hybrid mice 
were  added  to  target  tumor cells  derived from one of the parental  strains. 
F1 hybrid cells were not expected to react immunologically against parental 
cells since  recessively determined histocompatibility antigens have not been 
demonstrated in the H-2 systems of the mouse (19, 20). Therefore, the hybrid 
cells contain all histocompatibility factors present in the parental cells. How- 
ever, lymphoid cells  derived from F1 hybrid mice were found to be  able  to 
kill H-2  incompatible  tumor cells  (Table  I).  In fact,  they were  equally, or 
only slightly less,  efficient compared  to  homozygous allogeneic ceils.  It  was 
concluded  that  at  least  one component of this  reaction was  not related  to 
immunological phenomena  analogous  tt  those  observed  in  vivo.  It  seems 
more likely that target cell damage was caused by contact with foreign iso- 
antigens carried on the surface of the added lymphoid cells. 
As  demonstrated  previously  (12),  other  strain  differences not  related  to 
histoincompatibility at  the  H-2  locus  could  not  explain  the  effect,  since 
cytotoxicity occurred in cells from congenic resistant lines different only with 
regard to their H-2 isoantigens. 
Cytotoxicity  of  Parental  Nonimmune  Lymphoid  Cells on  Fx  Targets.--In 
view of the above findings, it was considered important to investigate whether 
lymphoid cells from a  parental strain would kill target ceils derived from an 
F1 hybrid strain produced by crossing the parental strain with an H-2 incom- 
patible strain. In this case, the target cells would not meet any foreign antigens 
on the added cells, since the targets contain all antigens present on the lymphoid 
cells.  The  results of some tests  of this  design  are  summarized in Table  II. 
In  all experiments,  a  significant cytotoxic effect of parental  lymphoid cells 
on  Fa  targets  was  observed.  In  Experiments  2  and  3,  this  cytotoxic effect 
was  qualitatively comparable  to  that obtained with allogeneic cells,  where- 
as in other experiments (1, 4, and 5) it was somewhat lower. 
Effect of X-Irradiation  on Cytotoxicity.--In these experiments, the possibility 
of the induction of a primary immune response exists since the lymphoid cells 
were confronted with foreign transplantation antigens present on the target 
cells.  However,  this  was  considered less  probable  since pretreatment of the 
lymphoid cells with X-ray doses of 1500-3000  R did not reduce their cytotoxic 
potency (Tables I and II). Similar doses of X-rays did not abolish cytotoxicity 
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As shown previously (21),  DNA synthesis in lymphoid cells was completely 
inhibited by these X-ray doses as determined by the incorporation of thymidine- 
14C  into  the  lymphoid cells even after  stimulation with  PHA.  Since semisyn- 
geneic and  X-irradiated allogeneic lymphoid cells were able  to  damage  target 
TABLE I 
Cytotoxic Effect of Nonimmune  AUogeneic and Semisyngeneic  F1 Hybrid Lymphoid  Cells on 
Parental Target Tumor Cells 
Exp. No.  Tumor 
MCAGA 
MCAGA 
MC57S 
MC57S 
MC57S 
MC57S 
MC57T 
Strain of 
origin 
A 
A 
C57BL 
C57BL 
C57BL 
C57BL 
Lymphoid cells 
derived from 
A 
C57BL 
A X  C57BL 
A 
A.CA 
C57BL 
A X  C57BL 
C57BL 
A 
A X  C57BL 
A.CA 
A.CA X  C57BL 
C57BL 
A 
A X  C57BL 
C57BL 
A.CA 
A.CA X  C57BL 
C57BL 
A.CA 
A.CA X  C57BL 
Pretreatment 
of lymphoid 
cells 
No.  of living 
tumor cells 
X  l0 s =t= s~ 
--  132  -4- 
--  444- 
--  73  4- 
22 
5 
5 
3000 R 
1500 R 
C57BL  C57BL 
A 
A X  C57BL 
C3H 
C3H X  C57BL 
200  4-  18 
93-4-7 
80  4-  9 
92-4-8 
188  4-  14 
283  4- 
180  4- 
181  4- 
173  4- 
"  197  -4- 
317  -4- 
--  84  ± 
--  32  -4- 
--  58  -4- 
110  -4- 
--  105  -4- 
--  61  -4- 
--  69  4- 
137  -4- 
--  41  4- 
--  15  -4- 
--  13  4- 
38  -4- 
--  79  4- 
--  31  4- 
--  27  -4- 
--  45  -4- 
--  41  -4- 
31 
18 
15 
16 
14 
14 
7 
3 
7 
21 
6 
12 
11 
15 
10 
2 
1 
4 
12 
6 
3 
5 
7 
Living cells 
in compari- 
son wtth 
controls 
% 
100 
33.3 
55.3 
100 
46.5 
40.0 
46.0 
94.0 
100 
63.6 
64.0 
61.1 
69.0 
> 100 
100 
38.1 
69.0 
> 100 
100 
58.1 
65.7 
>100 
100 
36.6 
31.7 
92.3 
100 
39.2 
34.2 
57.0 
51.9 ERNA  MOLLER  399 
Cytotoxi~ E:ffext of Nonimmune Allo 
Exp. No. 
TABLE II 
ene¢~ and Parental  Lymphoid Cells on Ft Hybrid 
Tar  et Tumor Cells 
Tumor 
MCAG 
MCAG 
MDHC 
MDHC 
MDHC 
MDHC 
Strain of origin 
A X  A.CA 
A X  A.CA 
C3H X  DBA 
C3H X  DBA 
C3H X  DBA 
C3H X  DBA 
Living 
Pretreat-  No. of living  cells  in  Origin of  ment of  lymphoid cells  lymphoid tumor  cells  comparison 
cells  X  lOS -4- sE  with 
controls 
% 
A X  A.CA  --  206  -4-  12  100 
A  --  130  -4-  9  63.1 
A.SW  --  57  4-  8  27.7 
--  204  4-  14  99.0 
A X  A.CA  3000 R  186  4-  18  100 
A  "  91  4-  16  48.9 
A.CA  "  95  -4-  10  51.1 
C3H  "  100  4-  10  53.8 
A X  C3H  "  83  4-  12  44.6 
C3H X  DBA  3000R  97  -4-  10  100 
C3H  "  44  4-  8  45.4 
A  "  54  4-  1  55.7 
--  114  4-  10  >100 
C3H X  DBA  1500 R  499  4-  118  100 
C3H  "  396  4-  70  79.4 
DBA  "  347  ±  42  69.5 
A  "  299  4-  43  59.9 
C57BL  "  386  -4-  82  77.4 
A.CA  "  338  4-  77  67.7 
C3H X  DBA  1500 R  55  4-  4  100 
C3H  "  43  4-  5  78.2 
DBA  "  36  :t:  10  65.5 
A.SW  "  34  4-  8  61.8 
C57BL  "  24  4-  7  43.6 
C3H X  DBA  1500R  112  4-  9  100 
C3H  "  87  4-  6  77.7 
DBA  "  76  4-  15  67.9 
cells, immune reactions appear unlikely, whereas the allogeneic inhibition con- 
cept  explains  the  findings adequately.  Parental  cells killed  F1  targets  to  the 
same extent as allogeneic lymphoid cells did and their effect was not abolished 
by X-irradiation. It seems likely, in view of these findings, that an analogous 
mechanism operates in the latter case. Since F1 target cells are not confronted 
with foreign antigens on parental lymphoid cells,  allogeneic inhibition in  the 
in the real sense cannot be applied as an explanation. However, the structural TABLE  III 
Suppression of Target Cell Deah by Pretreatmer~ of the Allogeneic Lymphoid  Cells zoith Specific 
Isoimmune Sera 
Target cells  Lymphoid 
cells 
Exp.  derived  Immune serum  No.  Designa- ' Strain of  from 
tion  origin  strain 
1  MC575  C57BL  C57BL  -- 
A  C57L-A 
A  DBA X  C57BL-A 
A  C3H ×  C57BL-A 
A  A.CA-A 
2  MC57G  C57BL  C57BL  C57BL-A 
C57BL 
A  C57BL-A 
A  DBA X  C57BL-A 
A  CBA X  C57BL-A 
A 
3  MC57G  C57BL  C57BL  C57BL-A 
C57BL  A  X  C57BL-ACA 
C57BL 
A  C57BL-A 
A  DBA  X  C57BL-A 
A  CBA X  C57BL-A 
A  A  X  C57BL-ACA 
4  MC57G  C57BL  C57BL  C57BL-A 
C57BL  A  X  C57BL-ACA 
C57BL 
A  C57BL-A 
A  DBA  X  C57BL-A 
A  CBA X  C57BL-A 
A  A  X  C57BL-ACA 
5  MC57G  C57BL  C57BL  C57BL-A 
C57BL  A  X  C57BL-ACA 
C57BL 
A  C57BL-A 
A  DBA  X  C57BL-A 
A  CBA X  C57BL-A 
A  A  X  C57BL-ACA 
A 
6  MC575  C57BL  C57BL  C57L-A 
C57BL 
A  C57L-A 
A  DBA  X  C57BL-A 
A  CBA X  C57BL-A 
A 
7  MC57T  C57BL  C57BL  C57L-A 
C57BL 
A  C57L-A 
A 
8  MCSTT  C57BL  C57BL  C57BL-A 
C57BL  C57BL ns 
A  C57BL-A 
A  C57BL ns 
1 
Immune serum  directed  I  No.  of  Living cells 
against  the  following  I  surviving  in 
lymphoid ceils H-2  tumor  comparison  ceils  X l0  s  with  isoantigens  :i:  sE  controls 
% 
--  128  4.  14  i00 
1, 3, 4, 8, 10,  11,  13,  23  116 4.  11  90.6 
1, 11, 25  62  4-  7  48.4 
4, 10,  13  68 4-  15  53.1 
3, 4, 5, 11,  13, 25,  28,  29  47 .4-  9  36.7 
None  181  4.  10  100 
--  185  q-  17  ~>100 
1, 3, 4, 8, 10,  11, 13, 25  151  -I-- 24  83.4 
1, 11, 25  88  4.4- 9  48.6 
4, 10, 13  74 4.  10  40.9 
--  46  -4-  8  25.4 
None  81  4.  25  100 
None  88  4.  16  >100 
1, 3, 4, 8, 10, 11, 13, 25  62  4.  16  76.5 
1, 11, 25  61  4. 9  75.3 
4, 10, 13  63  4.  11  77.8 
None  34  4.  3  42.0 
None  149  -4-  25  100 
None  129  4.  9  86.6 
--  124  4.  15  83.2 
1,3,4,8,10,11  13, 25  123-b  14  82.6 
1,  11, 25  90 4.  10  60.4 
4,  10, 13  94  4.  9  63,1 
None  90  4.  5  60.4 
None  149  4.  24  100 
None  150  4.  15  >100 
--  132 4.4- 17  88,6 
1, 3, 4, 8,  10, 11, 13, 25  120  4.4- 17  80.5 
1, 11, 25  72  4.  8  48.3 
4,  10, 13  81  4.  20  54.4 
None  76 4.  12  51.0 
--  55  -4-  6  36.9 
None  126  4.  24  100 
--  145  4.4-  12  >100 
1, 3, 4, 8, 10, 11, 13, 25  71  -4-  9  56.3 
1, 11, 25  64  4-  10  50.8 
4, 10, 13  63  4.  6  50.0 
--  70  4.  7  55.6 
None  170 4-  tt  100 
--  56  4.  8  80.0 
1, 3, 4, 8,  10, 11, 13, 25  43  4.  6  61.4 
--  12  ~:  4  17.1 
None  151  4.  17  100 
--  202  4.  15  >100 
1, 3, 4, 8,  10, 11, 13, 25  116  :t= 23  76.8 
--  89  :t:  8  58.9 
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Exp. 
No. 
Target ceils 
Designa-  Strain of 
fion  origin 
MC57T  C57BL 
MC57T  C57BL 
Lymphoid I 
cells  ] 
derived 
from 
strain 
C57BL 
C57BL 
A 
A 
A 
A 
C57BL 
C57BL 
A 
A 
A 
A 
Immune serum 
C57BL-A 
A  X  C57BL-ACA 
C57BL-A 
DBA  X  C57BL-A 
CBA X  C57BL-A 
A  X  C57BL-ACA 
A-A.  CA 
C57L-A 
C57L-A 
DBA  X  C57BL-A 
CBA ×  C57BL-A 
A-A.CA 
Immune serum directed 
against  the following 
lymphoid cells H-2 
moantigens 
None 
None 
1, 3, 4, 8, 10, 11, 13, 25 
1, 11, 25 
4, 10, 13 
None 
None 
None 
1, 3, 4, 8, 10, 11, 13, 25 
1, 11, 25 
4, 10, 13 
None 
No. of 
surviving 
tumor 
cells X  lO s 
,-4.. SE 
75  -t-  8 
98  .4-  17 
86-4- 7 
62  -4- ll 
47  "4- 7 
62  "4- 11 
78 -4-  15 
70 ~  10 
81+7 
30  -t-4 
$24-7 
334-6 
Living ceils 
in 
comparison 
with 
controls 
% 
100 
>100 
>10O 
82.7 
62.7 
82.7 
:>I00 
I00 
>100 
42.9 
74.3 
47.1 
arrangements of H-2 isoantigens are necessarily different on parental and hybrid 
cells.  It  seems  possible  that  structurally  and/or  antigenicaUy incompatible 
lymphoid cells can cause target destruction by close confrontation. 
Specific Suppression  of Cytotoxicity by Isoantibodies against the Allogeneic 
Lymphoid Cells.--In  terms of the allogeneic inhibition concept, it would be ex- 
pected that cytotoxicity is suppressed by blocking the antigenic receptors on 
the allogeneic lymphoid cells.  It seemed possible that this could be achieved 
by treating the lymphoid ceils with isoantibodies produced in the target strain 
and directed against the lymphoid cells. Tumors MC57G, MC57S, and MC57T 
indigenous to the C57BL strain were used for this study. Antisera against the 
allogeneic lymphoid cells of strain A  origin were produced in the tumor host 
strain. Antibodies "in C57BL mice against strain A are supposed to react with 
all the antigens on A cells that are different from the C57BL strain. Two other 
sera were also produced which are expected to contain antibodies only to some 
of the  antigens present on the lymphoid cells  and  absent from the targets. 
Such sera were produced in (C3H X  C57BL), (CBA X  C57BL)F1, and (DBA 
X  C57BL)Fx hybrids against strain A. Since C3H and CBA mice on the one 
hand and DBA on the other contribute antigens present in strain A and absent 
from C57BL, these sera will react only against some antigens in strain A which 
are absent in C57BL. For details of antiserum specificities  see Table III. The 
results of 10 experiments of this design are shown in Table III. In all experi- 
ments but one (Exp. 6), pretreatment of the A lymphoid cells with C57BL or 
C57L anti-A serum before addition to  the  C57BL tumor cells  resulted in a 
partial (Exps. 2, 3, 7, and 8) or almost complete (Exps.  1, 4, 5, 9, and 10) in- 
hibitiop of the cytotoxic reaction in comparison with the effect by untreated 
strain A  lymphocytes or the same cells  treated with isoantibodies not recog- 
nizing any of the relevant A antigens present on the lymphoid cells. 402  CYTOTOXICITY  BY  ALLOGENEIC LYMPHOID  CELLS 
Antisera expected to react with some but not all of the A histocompatibility 
antigens absent in C57BL caused a partial suppression of cytotoxicity in some 
experiments, whereas in others there was no detectable protective effect. Al- 
though these sera  contained antibodies against the lvanphoid cells,  complete 
inhibition of the reaction did not occur. Thus, suppression by the C57BL or 
C57L anti-A sera was specific and could not be explained by steric hindrance, 
lymphoid cell death, or leukoagglutinafion, all of which could occur theoreti- 
cally. It seems likely, therefore, that inhibition of the cytotoxic reaction  ob- 
tained in the present experiments was due to specific blocking by antibody of 
the antigenic determinants of the lymphoid cells, thereby interfering with the 
recognition of incompatibility by the target cells. 
DISCUSSION 
Cytotoxic effects of nonimmune lymphoid cells on incompatible target cells 
in vitro have recently been described by different authors (11,  12, 22-26).  In 
some of these publications, syngeneic (or autochthonous) controls demonstrated 
that the effect was related  to antigenic discrepancies rather  than to various 
nonspecific influences (11, 12, 23, 26). 
The presence of PHA or heterologous antibodies was found to be necessary 
for cytotoxicity with nonimmune allogeneic lymphoid cells (11,  12, 23, 24) or 
to accelerate cytotoxicity (26).  Although this reaction could represent the in- 
duction of a primary immune response in vitro, several findings suggested that 
at least one component of the reaction was nonimmunological. As documented 
above, semisyngeneic F1 hybrid lymphoid cells,  generally assumed unable to 
carry out immune reactions against parental targets for genetical reasons, were 
as e~icient as allogeneic  cells. Since several experiments of this type have been 
performed in congenic resistant lines of mice, being different only with regard to 
histocompatibility antigens of the H-2  system, it was concluded that target 
cell  confrontation with foreign histocompatibility antigens was  the  relevant 
variable  for  cytotoxicity  (allogeneic  inhibition)  (12).  This  conclusion  was 
strengthened in the tests described here by the finding that isoantibodies ca- 
pable of reacting with all the lymphoid cell antigens which were foreign to the 
targets suppressed  cytotoxicity, whereas antisera still reacting with the lym- 
phoid cell antigens, but not blocking all antigens foreign to the target cells, did 
not suppress cytotoxicity. 
Hellstr6m and his collaborators (13, 14, 27, 28) have put forward evidence 
indicating that the reduced growth of tumors in semisyngeneic F1 hybrids, as 
compared to syngeneic hosts, is dependant upon the confrontation of the tumor 
with foreign antigens present in the tumor recipients. In vitro studies revealed 
that antigenic extracts  of allogeneic  cells were able to inhibit the growth of 
cells in tissue culture, as compared to the effect of syngeneic antigenic extracts 
(14).  From Hellstr6m's and our own data, the conclusion was drawn that allo- ERNA M/)LLER  403 
geneic inhibition  is a  cytotoxic and/or growth-inhibiting  reaction induced by 
foreign histocompatibility antigens in a  number of different target cells, such 
as normal embryo cells (12,  23),  lymphoma  (27),  and  sarcoma cells  (11).  As 
postulated before (10),  the allogeneic  inhibition phenomenon may contribute 
to the cytotoxic effect of immune lymphoid cells. According  to this hypothesis, 
sensitized lymphoid cells would be equipped with specific receptors,  presumably 
of antibody nature, making recognition  and attachment possible to the targets, 
whereas actual target death would be caused by the allogeneic inhibition phe- 
nomenon. 
A cytotoxic reaction mediated by nonimmune lymphoid cells has also been 
observed in  human  systems; Holm and  Perlmann  have  shown  that  normal 
lymphocytes from peripheral blood can kill human Chang liver cells in culture 
in  the presence of PHA (29).  Their experiments suggested that  the lympho- 
cytes were probably not inactive during the cytotoxic process. Thus they dem- 
onstrated  that  lymphocytes  which  have  been  pretreated  with  PHA,  with 
staphylococcal toxin,  or with incompatible lymphocytes are more able  to kill 
target  cells  than  untreated  cells.  Furthermore,  they have  showed  that  lym- 
phocytes from peripheral  blood of leukemic patients were less capable of in- 
flicting target cell damage (30). Such cells do not undergo blast transformation 
as easily as cells from healthy donors.  Experiments with various metabolic in- 
hibitors suggested that inhibition of RNA or protein synthesis did not affect 
the potency of the lymphocytes in causing  target cell death,  whereas certain 
drugs  that  interfered  with  oxygen uptake  and  energy-consuming  processes 
were suppressing  (31). 
Other experiments with human cells have shown that allogeneic lymphocytes 
are more potent in causing  destruction of human fibroblast cell cultures than 
cells obtained from the autochthonous patient (26).  However, in some tests, 
autochthonous lymphocytes gave cytotoxic reactions,  although these reactions 
were always lower in intensity than those from allogeneic cells. The autochtho- 
nous reactions were caused to a  large extent by contaminating  granulocytes 
which became degranulated  in tissue  culture  and  presumably  released  lyso- 
somal  substances toxic  to  the target  cells. Pure  lymphocytes such as  those 
obtained from the thoracic duct were highly cytotoxic in the presence of PHA 
to allogeneic cells? Further studies on these problems are in progress. 
SUMMARy 
Nonimmune  lymphoid  cells  were  capable of  causing  cytotoxicity of H-2 
incompatible mouse tumor cells in vitro in the presence of PHA, whereas syn- 
geneic cells were not. Semisyngeneic  and X-irradiated (1500-3000 R) F1 hybrid 
lymphoid cells were cytotoxic for target cells derived from one of the parental 
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strains.  In  addition,  parental  nonimmune  and  X-irradiated  lymphoid  cells 
damaged  hybrid  target cells.  It was concluded  that  one component of cyto- 
toxicity was not related to an induction of a primary immune response in vitro, 
since F1 hybrid cells are not capable of reacting immunologically against paren- 
tal type target cells.  It seemed probable that cytotoxicity was caused by target 
cell  confrontation  with  antigenically  and/or  structurally  incompatible  lym- 
phoid cells.  This conclusion was strengthened  by the demonstration that iso- 
antibodies  produced  in  the  target  strain  and  directed  against  the  allogeneic 
lymphoid  cells  specifically  suppressed  cytotoxicity.  Isoantibodies  reacting 
against  some but not  all of the  antigenic determinants of the lymphoid cells 
differentiating  them from the  target cells did not suppress cytotoxicity. The 
specific suppression of  cytotoxicity by  specific isoantibodies against the lym- 
phoid cells support the allogeneic inhibition concept. 
The author wishes to thank Mrs. Lill-Britt Andersson for excellent technical assistance. 
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